Agora Labs
Mitchell Borin is a seasoned executive with extensive experience in business development and commercial leadership within the life sciences and healthcare sectors. Currently serving as an Advisory Board Member at Agora Labs since September 2024, Borin previously held the position of Chief Commercial Officer at Trueblue, where responsibilities included leading commercial functions to enhance the Life Science industry's experience through AI and innovative technologies. Prior roles include Vice President of Business Development at Genpact, where digital-led transformation was a focus, and commercial leadership positions at Accenture, including Commercial Sales Lead for the Emerging Biotech sector. Borin's earlier experience includes business development roles at Thermo Fisher Scientific, ACS Services, Inc., and a sales position at UnitedHealth Group. Educational credentials include an MBA in Finance from Boston College Carroll School of Management and a BS in Chemistry from Boston College, in addition to studies at the University of Sydney.
This person is not in any teams
This person is not in any offices
Agora Labs
Agora Labs is building the new real-time health data ecosystem. The platform solves privacy and data quality, so that researchers and engineers can deliver insights and products built on real-world evidence at scale. Agora is powering real-time, secure access to multi-modal, longitudinal health data – privacy guaranteed. We make real-world data accessible and seamlessly interconnected between hospitals, life science companies and AI developers to reduce the cost of data and fuel faster and safer innovation. We automatically curate, standardize and activate data for research and for developing AI systems in the clinical setting. Founded in 2022 by medical doctors, MIT scientists and cryptographers, Agora is a deep-tech company bridging ethics, AI, and medicine through the value of data.